Pcn197 - Cost Utility Analysis of First-Line Paclitaxel With Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab Versus Pemetrexed With Carboplatin Followed by Maintenance Pemetrexed in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer in Lebanon

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.279
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2013English

P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Induction of Peripheral Effector CD8 T Cell Proliferation by Combination of Paclitaxel, Carboplatin and Bevacizumab in Non-Small Cell Lung Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2019English

P1.01-87 a Phase 1b Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Patients With Stage 4 Non-Squamous Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Analysis of Continuous First‑line Treatment With Docetaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy